We are on a mission to transform COPD Patients’ outcomes through early prediction of exacerbations       

Worldwide nearly 400 million people suffer from Chronic Obstructive Pulmonary Disease (COPD), a chronic degenerative lung disease characterized by persistent respiratory symptoms and health deteriorating exacerbations. The exacerbations result in faster decline in lung function, poorer quality of life and increased mortality​

Patients diagnosed with COPD lack reliable and early diagnostics solutions to monitor their health. Once patients notice their symptoms it is often too late for early medical intervention. Consequently, 20% of COPD patients are hospitalized due to their exacerbation.

​BreathSense is an EIC Pathfinder project dedicated to developing a cutting-edge portable breathalyser with an innovative clinical workflow, that can provide real-time, non-invasive, at-home patient monitoring. This will allow for the early prediction of exacerbations in patients living with COPD, with the goal to transform COPD patient outcomes. BreathSense brings together a distinguished international consortium of renowned academic institutions, medical research organisations, technology experts and innovative SME’s to transform COPD patient care.

For more details go to our project page or learn more about our esteemed international consortium partners.